ATE446290T1 - Substituierte n-acyl-homoserinlactone - Google Patents

Substituierte n-acyl-homoserinlactone

Info

Publication number
ATE446290T1
ATE446290T1 AT07733705T AT07733705T ATE446290T1 AT E446290 T1 ATE446290 T1 AT E446290T1 AT 07733705 T AT07733705 T AT 07733705T AT 07733705 T AT07733705 T AT 07733705T AT E446290 T1 ATE446290 T1 AT E446290T1
Authority
AT
Austria
Prior art keywords
acyl homoserine
substituted
homoserine lactones
lactones
acyl
Prior art date
Application number
AT07733705T
Other languages
English (en)
Inventor
David Idris Pritchard
Siri Ram Chhabra
Original Assignee
Secr Defence
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Secr Defence filed Critical Secr Defence
Application granted granted Critical
Publication of ATE446290T1 publication Critical patent/ATE446290T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT07733705T 2006-05-22 2007-05-22 Substituierte n-acyl-homoserinlactone ATE446290T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0610042.4A GB0610042D0 (en) 2006-05-22 2006-05-22 Substituted n-acyl homoserine lactones
PCT/GB2007/050284 WO2007135466A2 (en) 2006-05-22 2007-05-22 Substituted n-acyl homoserine lactones

Publications (1)

Publication Number Publication Date
ATE446290T1 true ATE446290T1 (de) 2009-11-15

Family

ID=36660536

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07733705T ATE446290T1 (de) 2006-05-22 2007-05-22 Substituierte n-acyl-homoserinlactone

Country Status (10)

Country Link
US (1) US8049020B2 (de)
EP (1) EP2044046B1 (de)
JP (1) JP2009537625A (de)
CN (1) CN101506186A (de)
AT (1) ATE446290T1 (de)
AU (1) AU2007252999A1 (de)
DE (1) DE602007002920D1 (de)
ES (1) ES2334286T3 (de)
GB (2) GB0610042D0 (de)
WO (1) WO2007135466A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102757437B (zh) * 2012-06-12 2014-10-15 中国科学院化学研究所 酞菁纳米棒阵列薄膜及其制备方法与应用
CN103980233B (zh) * 2013-02-08 2017-07-04 中国人民解放军军事医学科学院毒物药物研究所 一种高丝氨酸内酯类衍生物、其制备方法和用途
WO2014153415A2 (en) * 2013-03-19 2014-09-25 The Scripps Research Institute Trail enhancers for the selective killing of cancer cells
CN104496737B (zh) * 2014-12-13 2017-12-22 西安近代化学研究所 一种合成α‑胺甲酰基氟乙酸酯化合物的方法
CN104529802A (zh) * 2014-12-13 2015-04-22 西安近代化学研究所 一种合成n,n′-双取代氟代丙二酰胺化合物的方法
US10195177B2 (en) 2015-10-01 2019-02-05 The University Of Toledo Use of acyl-homoserine lactone derivatives as anti-thrombotic agents
CN110003148B (zh) * 2019-04-29 2023-03-24 安徽安力肽生物科技有限公司 一种高丝氨酸内酯盐酸盐的制备方法
IL305673A (en) 2021-03-09 2023-11-01 Basf Se Melonamides and their use as herbicides

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2904556A (en) * 1958-08-06 1959-09-15 Dow Chemical Co Phthalides
GB9108307D0 (en) * 1991-04-18 1991-06-05 Univ Nottingham Autoinducer
DK0706393T3 (da) * 1993-07-02 2000-04-03 Univ Nottingham Immun-undertrykkende og antiallergiske forbindelser, f.eks. N-(3-oxohexanoyl)homoserin-lacton
US6337347B1 (en) * 1998-06-18 2002-01-08 The Research & Development Institute, Inc. Autoinducer compounds
GB0007588D0 (en) * 2000-03-30 2000-05-17 Univ Nottingham N-Acyl homoserine lactones

Also Published As

Publication number Publication date
AU2007252999A1 (en) 2007-11-29
GB0822066D0 (en) 2009-01-07
ES2334286T3 (es) 2010-03-08
GB2452436A (en) 2009-03-04
WO2007135466A2 (en) 2007-11-29
EP2044046A2 (de) 2009-04-08
JP2009537625A (ja) 2009-10-29
US8049020B2 (en) 2011-11-01
US20100286261A1 (en) 2010-11-11
WO2007135466A3 (en) 2008-01-10
EP2044046B1 (de) 2009-10-21
DE602007002920D1 (de) 2009-12-03
GB0610042D0 (en) 2006-06-28
CN101506186A (zh) 2009-08-12

Similar Documents

Publication Publication Date Title
ATE446290T1 (de) Substituierte n-acyl-homoserinlactone
TW200604175A (en) Ortho substituted aryl or heteroaryl amide compounds
WO2005105732A8 (en) Substituted methyl aryl or heteroaryl amide compounds
GT200500286A (es) Analogos de anilino-pirimidina
MX2009010024A (es) Nuevo compuesto de adenina.
MY152972A (en) Azabicyclo compound and salt thereof
WO2005092895A3 (en) Alpha aryl or heteroaryl methyl beta piperidino propanoic acid compounds as orl1-receptor antagonists
MX2009012885A (es) Nuevo derivado de 1,2,3,4-tetrahidroquinoxalina que tiene, como sustituyente, grupo fenilo que tiene estructura de ester de acido sulfonico o estructura de amida de acido sulfonico introducida en este, y tiene actividad de enlace al receptor de gluco
SE0300956L (sv) Stabilisatorblandningar
MY148312A (en) Benzazepine derivatives useful as vasopressin antagonists
EP2594555A4 (de) Heterozyklische verbindung und p27-kip-1-abbauhemmer
ATE494952T1 (de) Antibackmittel für düngemittel
DE602004030004D1 (de) Verbindungen zur behandlung von stoffwechselstörungen
MX2009008772A (es) Derivado piridil-triazolopirimidina o su sal, pesticida que lo contiene y proceso para su produccion.
DE602006005227D1 (de) Len und tropolon
WO2008001946A3 (en) Pesticidal composition comprising tetrafluorobenzyl cyclopropane carboxylates
AR028802A1 (es) El uso de ciertos compuestos de ftalazina para el tratamiento de enfermedades neovasculares oculares
WO2007033039A3 (en) Proteasome inhibiting beta lactam compounds
AR057909A1 (es) Proceso para preparar montelukast y compuestos relacionados, que utiliza un compuesto intermediario derivado de un ester sulfonico.
EP2604261A3 (de) SCCA-1-Produktionshemmer mit einem Carboxamidderivat und/oder einem Salz daraus als Wirkstoff
WO2003075928A3 (en) Stable pharmaceutical compositions
EP2597093A4 (de) Benzofuranonverbindung und pharmazeutische zusammensetzung damit
ATE318265T1 (de) Amidin-derivate, ihre herstellung und verwendung als medikamenten
CO5580804A2 (es) Derivados de diazepanes utiles como inhibidores de lfa
ATE450519T1 (de) 1,2,4-thiadiazolverbindungen und diese enthaltende zusammensetzung zur bekämpfung von arthropoden

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties